Clincosm LogoSign in Get a demo

renal cell carcinoma

Showing 1 - 25 of 513
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Functioning Kidney, Renal Cell Carcinoma Trial (Laparoscopic Surgery)

Not yet recruiting
  • Non-Functioning Kidney
  • Renal Cell Carcinoma
  • Laparoscopic Surgery
  • (no location specified)
Nov 11, 2023

Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pucotenlimab Combined With Lenvatinib
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen University Cancer Center
Nov 10, 2023

Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

Recruiting
  • Prostate Cancer
  • +3 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

NSCLC, Renal Cell Carcinoma, Melanoma Trial (Pembrolizumab co-formulated with hyaluronidase, Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Pembrolizumab co-formulated with hyaluronidase
  • Pembrolizumab
  • (no location specified)
Oct 19, 2023

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

    Withdrawn
    • Advanced Solid Tumor
    • +9 more
    • (no location specified)
    Oct 16, 2023

    PET/MR for Characterization of Renal Masses (RMs)

    Recruiting
    • Renal Tumor
    • +2 more
    • 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Oct 5, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

    Recruiting
    • Renal Cell Carcinoma
    • +3 more
    • Arterial Doppler for Flow Mediated Reserve measurement
    • Paris, France
      INstitut Mutualiste Montsouris
    Aug 29, 2023

    Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer Trial in Nanchang (CD70 CAR-T cells)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • CD70 CAR-T cells
    • Nanchang, Jiangxi, China
      The First Affiliated Hospital of Nanchang University
    Aug 23, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

    Not yet recruiting
    • Renal Cancer
    • +3 more
    • Aurora, Colorado
      University of Colorado Cancer Center
    Jul 24, 2023

    Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Jul 13, 2023

    Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Cytoreductive Nephrectomy
    • (no location specified)
    Jul 3, 2023

    RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

    Not yet recruiting
    • RCC
    • Renal Cell Carcinoma
    • Cabozantinib 80 MG
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 3, 2023

    Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

    Recruiting
    • Carcinoma
    • +4 more
      • Nanjing, Jiangsu, China
        Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
      Jun 30, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Clinical Significance of Adherent Perinephric Fat in Patients

      Recruiting
      • Renal Cell Carcinoma
      • +4 more
        • Otwock, Poland
          European Health Centre, Second Department of Urology, Centre of
        May 31, 2023

        Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

        Not yet recruiting
        • Melanoma
        • +5 more
        • RC198 Injection
        • Auchenflower, Queensland, Australia
          Research Site
        May 17, 2023

        Genomic Data of American Indian Patient Population

        Active, not recruiting
        • Immune Checkpoint Inhibitors
        • +6 more
        • Immunotherapy
        • Tucson, Arizona
        • +5 more
        May 8, 2023